BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35023102)

  • 1. Early and Very Early GRIM19 and MCL1 Expression Are Correlated to Late Acquired Prednisolone Effects in a T-Cell Acute Leukemia Cell Line.
    G L; Adamaki M; Hatziagapiou K; Geronikolou SA; Tsartsalis AN; Vlahopoulos S
    Adv Exp Med Biol; 2021; 1339():147-160. PubMed ID: 35023102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.
    Lambrou GI; Adamaki M; Hatziagapiou K; Vlahopoulos S
    Curr Drug Res Rev; 2020; 12(2):131-149. PubMed ID: 32077838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance.
    Ariës IM; Hansen BR; Koch T; van den Dungen R; Evans WE; Pieters R; den Boer ML
    Haematologica; 2013 Dec; 98(12):1905-11. PubMed ID: 24142999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis Induced by Prednisolone Occurs without Altering the Promoter Methylation of BAX and BCL-2 Genes in Acute Lymphoblastic Leukemia Cells CCRF-CEM.
    Ganbarjeddi S; Azimi A; Zadi Heydarabad M; Hemmatzadeh M; Mohammadi S; Mousavi Ardehaie R; Zamani M; Baharaghdam S; Esmaeili S; Ghasemi A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):523-529. PubMed ID: 32102534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines.
    Junk S; Cario G; Wittner N; Stanulla M; Scherer R; Schlegelberger B; Schrappe M; von Neuhoff N; Lauten M
    Klin Padiatr; 2015 May; 227(3):123-30. PubMed ID: 25985447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia.
    Durmaz B; Bagca BG; Cogulu O; Susluer SY; Alpay A; Aksoylar S; Gunduz C
    Biomed Res Int; 2021; 2021():3207328. PubMed ID: 34877353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
    Sai S; Nakagawa Y; Yamaguchi R; Suzuki M; Sakaguchi K; Okada S; Seckl JR; Ohzeki T; Chapman KE
    Leuk Res; 2011 Dec; 35(12):1644-8. PubMed ID: 21794917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
    Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
    Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Hub Genes Associated with Resistance to Prednisolone in Acute Lymphoblastic Leukemia Based on Weighted Gene Co-expression Network Analysis.
    Nekoeian S; Ferdowsian S; Asgari Y; Azizi Z
    Mol Biotechnol; 2023 Nov; 65(11):1913-1922. PubMed ID: 36877306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment.
    Ghasemi A; Khanzadeh T; Zadi Heydarabad M; Khorrami A; Jahanban Esfahlan A; Ghavipanjeh S; Gholipour Belverdi M; Darvishani Fikouhi S; Darbin A; Najafpour M; Azimi A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2319-2323. PubMed ID: 30141309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells.
    Bindreither D; Ecker S; Gschirr B; Kofler A; Kofler R; Rainer J
    BMC Genomics; 2014 Aug; 15(1):662. PubMed ID: 25103118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells.
    Inoue C; Sobue S; Kawamoto Y; Nishizawa Y; Ichihara M; Abe A; Hayakawa F; Suzuki M; Nozawa Y; Murate T
    Biochem Biophys Res Commun; 2020 May; 525(4):1074-1080. PubMed ID: 32184020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Mechanisms of Metabolism and Gene Expression of the CCRF-CEM Leukemia Cells under Glucocorticoid Treatment.
    Lambrou GI; Karakonstantakis T; Vlahopoulos S; Zaravinos A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL.
    Spijkers-Hagelstein JA; Pinhanços SS; Schneider P; Pieters R; Stam RW
    Leukemia; 2014 Apr; 28(4):761-9. PubMed ID: 23958920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration.
    Ouimet M; Drouin S; Lajoie M; Caron M; St-Onge P; Gioia R; Richer C; Sinnett D
    Oncotarget; 2017 Jan; 8(5):7477-7488. PubMed ID: 27980230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Glutaminolysis Shows Efficacy in Both Prednisolone-Sensitive and in Metabolically Rewired Prednisolone-Resistant B-Cell Childhood Acute Lymphoblastic Leukaemia Cells.
    Sbirkov Y; Vergov B; Dzharov V; Schenk T; Petrie K; Sarafian V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW
    Leukemia; 2013 Apr; 27(5):1063-71. PubMed ID: 23334362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
    Lambrou GI; Vlahopoulos S; Papathanasiou C; Papanikolaou M; Karpusas M; Zoumakis E; Tzortzatou-Stathopoulou F
    Leuk Res; 2009 Dec; 33(12):1684-95. PubMed ID: 19450877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.